Opendata, web and dolomites

GLADIATOR SIGNED

Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GLADIATOR project word cloud

Explore the words cloud of the GLADIATOR project. It provides you a very rough idea of what is the project "GLADIATOR" about.

bio    environment    designed    internet    radiofrequency    despite    cell    vision    time    demand    drastic    transforming    malignancies    reprogramming    sub    nano    disorders    interventions    nanomachines    components    communications    wireless    cellular    things    pathologies    clinically    biological    establishes    grim    life    shift    framework    insc    coupled    complete    evolution    ushering    network    external    optoelectronic    discipline    interface    nanotechnology    sciences    prototype    prognosis    brain    platform    ecmc    revolutionary    underlying    nanomachine    diagnostics    nanonetwork    channels    micro    progress    stem    solution    nanonetworks    engineering    detrimental    inscs    neural    sensors    cancer    autonomously    industry    appropriate    conceptual    release    socioeconomic    therapeutic    electronic    vanguard    tumours    societal    communication    multiforme    faceted    burgeoning    ict    implantable    bridging    supra    mirnas    first    rationally    externally    engineered    emergence    oncology    organoids    breakthrough    stimulation    exosomal    molecular    recurrence    proof    generate    fluorescent    radical    autonomous    host    tumour    glioblastoma    interfering    intervention    paradigm    autologous    anticipated    spatiotemporal    promises    building    gladiator    hybrid    consisting    therapy    renewal    cells    theranostic    therapeuticdiagnostic    applicable    delivering    monitor   

Project "GLADIATOR" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF CYPRUS 

Organization address
address: KALLIPOLEOS STREET 75
city: NICOSIA
postcode: 1678
website: www.ucy.ac.cy

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Cyprus [CY]
 Total cost 6˙122˙255 €
 EC max contribution 5˙982˙255 € (98%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF CYPRUS CY (NICOSIA) coordinator 953˙125.00
2    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) participant 1˙758˙103.00
3    E.P.O.S. IASIS RESEARCH AND DEVELOPMENT LTD CY (LEFKOSIA) participant 1˙111˙540.00
4    OULUN YLIOPISTO FI (OULU) participant 950˙535.00
5    NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU NO (TRONDHEIM) participant 787˙076.00
6    WATERFORD INSTITUTE OF TECHNOLOGY IE (Waterford) participant 421˙875.00
7    OSAKA UNIVERSITY JP (OSAKA) participant 0.00

Map

 Project objective

Brain pathologies are highly complex disorders. Despite recent progress, their prognosis is grim, defining a high societal challenge. Bridging life sciences, bio-nanotechnology, engineering and ICT, GLADIATOR promises a vanguard and comprehensive theranostic (therapeuticdiagnostic) solution for brain malignancies. Through a multi-faceted breakthrough, GLADIATOR will provide, for the first time, a working prototype of a complete, autonomous and clinically applicable, nanonetwork-based, Molecular Communications system based on the conceptual framework of Externally Controllable Molecular Communications (ECMC). Using Glioblastoma Multiforme tumours, the most detrimental brain pathologies, as a proof-of-concept case, GLADIATOR will implement a platform of cell-based and electronic components. Implantable autologous organoids of engineered neural stem cells (iNSCs) will release rationally designed exosomal bio-nanomachines, delivering reprogramming (therapeutic) miRNAs and building nanonetworks. Interfering with the underlying biological environment, the nanonetworks will define a revolutionary intervention. A hybrid bio-electronic interface, consisting of coupled external and implantable devices, will enable communication channels with host-derived fluorescent bio-nanomachines via micro-optoelectronic sensors. The cellular, sub-cellular and electronic components will be integrated into a wireless ECMC network. This system will autonomously monitor the spatiotemporal tumour evolution and recurrence and generate, on demand, appropriate reprogramming interventions, by radiofrequency stimulation of iNSC renewal. A paradigm shift in Oncology Research is anticipated via the supra-discipline of “bio-nanomachine diagnostics”. GLADIATOR establishes a radical long-term vision leading to a drastic change in cancer therapy, also ushering the emergence of the ECMC field and transforming the burgeoning industry of Internet of Nano-bio-things, with high socioeconomic impact.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLADIATOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLADIATOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

BESAFE (2019)

ARTIFICIAL INTELLIGENCE ENHANCEMENT OF SURGICAL TECHNOLOGY FOR THE REDUCTION OF HUMAN BEHAVIOUR-RELATED SURGICAL ACCIDENTS

Read More  

NOVIRUSES2BRAIN (2019)

''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

Read More